Role Overview
- Serve as a strategic partner at the intersection of commercial access, pricing & contracting, and clinical development.
- Advance pipeline pricing strategy, optimize gross-to-net (GTN) performance for CARVYKTI and future assets, and integrate payer and HEOR insights into clinical trial design and evidence generation.
Key Responsibilities
- Pipeline Pricing Strategy
- Lead development of evidence-based pricing frameworks for pipeline assets (including next-generation CAR-T), using global benchmarks, competitive positioning, and value-based pricing principles.
- Partner with RWE, Medical Affairs, and Clinical Development to support pipeline pricing and reimbursement positioning.
- Conduct scenario analyses and war-gaming exercises to stress-test pricing assumptions against competitive launches, formulary dynamics, and policy changes.
- Collaborate with Global Marketing and ex-US teams on international reference pricing implications and global launch sequencing.
- Gross-to-Net (GTN) Optimization
- Own commercial GTN modeling and forecasting with Finance and Contracts & Pricing; maintain accuracy across rebate, co-pay assistance, 340B, and other discount line items.
- Payer Insight Integration into Clinical Development
- Serve as primary Market Access liaison to Clinical Development and Medical Affairs; embed payer evidence requirements early in trial design.
- Translate payer, P&T committee, and HTA feedback into actionable recommendations for endpoints, comparators, patient populations, and PRO instruments (Phase 1β3).
- Identify unmet evidentiary needs across current and pipeline assets.
- Lead early payer advisory boards and simulated HTA exercises (e.g., ICER, NICE dossier prep) to pressure-test clinical evidence packages pre-filing.
- Partner with HEOR to design RWE studies, registries, and outcomes tracking to support durable formulary positioning post-launch.
- Payer Engagement & Stakeholder Management
- Build and maintain senior relationships with national and regional payer medical directors and pharmacy directors (commercial and government).
- Lead preparation of payer dossiers, value frameworks, and budget impact models for formulary submissions.
- Support government affairs/policy on CMS CAR-T reimbursement policy (MS-DRG, outpatient CAR-T coverage, Medicare Part B/D).
- Represent Market Access at AMCP, ISPOR, ASCO, and internal leadership reviews.
Requirements
- Bachelorβs degree required; advanced degree (MBA, PharmD, MPH, or PhD) strongly preferred.
- 7+ years of progressive life sciences experience.
- Demonstrated expertise in pricing strategy, GTN modeling, and contracting in life sciences.
- Prior experience integrating insights into business decision-making.
- Strong command of the U.S. payer landscape (commercial formulary dynamics, Medicare Part B/D coverage, Medicaid best price, and 340B).
- Proficiency in financial modeling, budget impact analysis, and scenario planning tools.
- Excellent executive communication and presentation skills; ability to distill complex access dynamics for C-suite audiences.
Preferred
- Experience with CAR-T, gene therapy, or other one-time high-cost therapies and their reimbursement challenges.
- Familiarity with outcomes-based contracting models and episodes of care.
- Experience presenting to C-suite leadership.
- Existing relationships within access and reimbursement.
Benefits (explicitly stated)
- Medical, dental, and vision insurance; 401(k) retirement plan with company match (vests fully on day one).
- Eight (8) weeks paid parental leave after three (3) months of employment.
- Paid time off including vacation, personal time, sick time, floating holidays, and eleven (11) company holidays.
- Voluntary benefits: flexible spending and health savings accounts; life and AD&D insurance; short- and long-term disability; legal assistance; supplemental plans (pet, critical illness, accident, hospital indemnity); commuter benefits; family planning and care resources; well-being initiatives; peer-to-peer recognition programs.